Long‐lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient

BACKGROUND The treatment of patients with acute leukemia, who due to their religious beliefs refuse to accept blood transfusion, is a great challenge for hematologists. CASE REPORT We present a case of acute pre‐T‐lymphoblastic leukemia in a Jehovah's Witness who did not accept blood transfusio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transfusion (Philadelphia, Pa.) Pa.), 2016-10, Vol.56 (10), p.2438-2442
Hauptverfasser: Chojnowski, Krzysztof, Janus, Agnieszka, Bliźniewska, Katarzyna, Robak, Marta, Treliński, Jacek
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2442
container_issue 10
container_start_page 2438
container_title Transfusion (Philadelphia, Pa.)
container_volume 56
creator Chojnowski, Krzysztof
Janus, Agnieszka
Bliźniewska, Katarzyna
Robak, Marta
Treliński, Jacek
description BACKGROUND The treatment of patients with acute leukemia, who due to their religious beliefs refuse to accept blood transfusion, is a great challenge for hematologists. CASE REPORT We present a case of acute pre‐T‐lymphoblastic leukemia in a Jehovah's Witness who did not accept blood transfusion during chemotherapy. Standard induction and consolidation chemotherapy was used (according to the PALG ALL‐6 regiment). RESULTS During consolidation cycles, darbepoietin alfa, intravenous iron, and total parenteral nutrition was administered. Extreme (Hb 
doi_str_mv 10.1111/trf.13703
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1828424883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4213980461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3203-b6fc7f8f120608aeadc351dc47d8256cb44927d594705db9731a9d24f72f667e3</originalsourceid><addsrcrecordid>eNp1kM1Kw0AQxxdRbK0efAFZ8CAe0u5Hkk2OUqwfFASpeAybZLZNzZe7GzU3H8Fn9ElMm-rNgWFg-M1_4IfQKSVj2tXEajWmXBC-h4bU48JhYejtoyEhLnUo5WyAjoxZE0JYSOghGjDBA88XdIiqeVUuvz-_cmlsVi4xfFgNBWBZQpFJnDZ6s7Ur2LSWdYsrhWXSWMB5W9SrKt5eJjiH5mV7kpVY4ntYVW9ydWHwc2ZLMAbX0mZQ2mN0oGRu4GQ3R-hpdr2Y3jrzh5u76dXcSTgj3Il9lQgVKMqITwIJMk24R9PEFWnAPD-JXTdkIvVCVxAvjUPBqQxT5irBlO8L4CN03ufWunptwNhoXTW67F5GNGCBy9wg4B112VOJrozRoKJaZ4XUbURJtFEbdWqjrdqOPdslNnEB6R_567IDJj3wnuXQ_p8ULR5nfeQPVESEfQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1828424883</pqid></control><display><type>article</type><title>Long‐lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Chojnowski, Krzysztof ; Janus, Agnieszka ; Bliźniewska, Katarzyna ; Robak, Marta ; Treliński, Jacek</creator><creatorcontrib>Chojnowski, Krzysztof ; Janus, Agnieszka ; Bliźniewska, Katarzyna ; Robak, Marta ; Treliński, Jacek</creatorcontrib><description>BACKGROUND The treatment of patients with acute leukemia, who due to their religious beliefs refuse to accept blood transfusion, is a great challenge for hematologists. CASE REPORT We present a case of acute pre‐T‐lymphoblastic leukemia in a Jehovah's Witness who did not accept blood transfusion during chemotherapy. Standard induction and consolidation chemotherapy was used (according to the PALG ALL‐6 regiment). RESULTS During consolidation cycles, darbepoietin alfa, intravenous iron, and total parenteral nutrition was administered. Extreme (Hb &lt; 5 g/dL), long‐lasting (41 days) anemia was observed with the lowest Hb concentration amounting to 1.3 g/dL (lasting 7 days). CONCLUSION We believe this to be the lowest Hb value observed, particularly one that persisted for such a long period of time and resulted in the patient surviving without consequences. The patient remains in complete remission for more than 2 years after diagnosis.</description><identifier>ISSN: 0041-1132</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1111/trf.13703</identifier><identifier>PMID: 27385671</identifier><identifier>CODEN: TRANAT</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Anemia - chemically induced ; Anemia - therapy ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Blood Transfusion ; Darbepoetin alfa - therapeutic use ; Hematinics - therapeutic use ; Hemoglobins - analysis ; Humans ; Iron - administration &amp; dosage ; Jehovah's Witnesses ; Male ; Parenteral Nutrition, Total ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Remission Induction ; Treatment Refusal ; Young Adult</subject><ispartof>Transfusion (Philadelphia, Pa.), 2016-10, Vol.56 (10), p.2438-2442</ispartof><rights>2016 AABB</rights><rights>2016 AABB.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3203-b6fc7f8f120608aeadc351dc47d8256cb44927d594705db9731a9d24f72f667e3</citedby><cites>FETCH-LOGICAL-c3203-b6fc7f8f120608aeadc351dc47d8256cb44927d594705db9731a9d24f72f667e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ftrf.13703$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ftrf.13703$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27385671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chojnowski, Krzysztof</creatorcontrib><creatorcontrib>Janus, Agnieszka</creatorcontrib><creatorcontrib>Bliźniewska, Katarzyna</creatorcontrib><creatorcontrib>Robak, Marta</creatorcontrib><creatorcontrib>Treliński, Jacek</creatorcontrib><title>Long‐lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient</title><title>Transfusion (Philadelphia, Pa.)</title><addtitle>Transfusion</addtitle><description>BACKGROUND The treatment of patients with acute leukemia, who due to their religious beliefs refuse to accept blood transfusion, is a great challenge for hematologists. CASE REPORT We present a case of acute pre‐T‐lymphoblastic leukemia in a Jehovah's Witness who did not accept blood transfusion during chemotherapy. Standard induction and consolidation chemotherapy was used (according to the PALG ALL‐6 regiment). RESULTS During consolidation cycles, darbepoietin alfa, intravenous iron, and total parenteral nutrition was administered. Extreme (Hb &lt; 5 g/dL), long‐lasting (41 days) anemia was observed with the lowest Hb concentration amounting to 1.3 g/dL (lasting 7 days). CONCLUSION We believe this to be the lowest Hb value observed, particularly one that persisted for such a long period of time and resulted in the patient surviving without consequences. The patient remains in complete remission for more than 2 years after diagnosis.</description><subject>Anemia - chemically induced</subject><subject>Anemia - therapy</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Blood Transfusion</subject><subject>Darbepoetin alfa - therapeutic use</subject><subject>Hematinics - therapeutic use</subject><subject>Hemoglobins - analysis</subject><subject>Humans</subject><subject>Iron - administration &amp; dosage</subject><subject>Jehovah's Witnesses</subject><subject>Male</subject><subject>Parenteral Nutrition, Total</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Remission Induction</subject><subject>Treatment Refusal</subject><subject>Young Adult</subject><issn>0041-1132</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1Kw0AQxxdRbK0efAFZ8CAe0u5Hkk2OUqwfFASpeAybZLZNzZe7GzU3H8Fn9ElMm-rNgWFg-M1_4IfQKSVj2tXEajWmXBC-h4bU48JhYejtoyEhLnUo5WyAjoxZE0JYSOghGjDBA88XdIiqeVUuvz-_cmlsVi4xfFgNBWBZQpFJnDZ6s7Ur2LSWdYsrhWXSWMB5W9SrKt5eJjiH5mV7kpVY4ntYVW9ydWHwc2ZLMAbX0mZQ2mN0oGRu4GQ3R-hpdr2Y3jrzh5u76dXcSTgj3Il9lQgVKMqITwIJMk24R9PEFWnAPD-JXTdkIvVCVxAvjUPBqQxT5irBlO8L4CN03ufWunptwNhoXTW67F5GNGCBy9wg4B112VOJrozRoKJaZ4XUbURJtFEbdWqjrdqOPdslNnEB6R_567IDJj3wnuXQ_p8ULR5nfeQPVESEfQ</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Chojnowski, Krzysztof</creator><creator>Janus, Agnieszka</creator><creator>Bliźniewska, Katarzyna</creator><creator>Robak, Marta</creator><creator>Treliński, Jacek</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope></search><sort><creationdate>201610</creationdate><title>Long‐lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient</title><author>Chojnowski, Krzysztof ; Janus, Agnieszka ; Bliźniewska, Katarzyna ; Robak, Marta ; Treliński, Jacek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3203-b6fc7f8f120608aeadc351dc47d8256cb44927d594705db9731a9d24f72f667e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anemia - chemically induced</topic><topic>Anemia - therapy</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Blood Transfusion</topic><topic>Darbepoetin alfa - therapeutic use</topic><topic>Hematinics - therapeutic use</topic><topic>Hemoglobins - analysis</topic><topic>Humans</topic><topic>Iron - administration &amp; dosage</topic><topic>Jehovah's Witnesses</topic><topic>Male</topic><topic>Parenteral Nutrition, Total</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Remission Induction</topic><topic>Treatment Refusal</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chojnowski, Krzysztof</creatorcontrib><creatorcontrib>Janus, Agnieszka</creatorcontrib><creatorcontrib>Bliźniewska, Katarzyna</creatorcontrib><creatorcontrib>Robak, Marta</creatorcontrib><creatorcontrib>Treliński, Jacek</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chojnowski, Krzysztof</au><au>Janus, Agnieszka</au><au>Bliźniewska, Katarzyna</au><au>Robak, Marta</au><au>Treliński, Jacek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long‐lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><addtitle>Transfusion</addtitle><date>2016-10</date><risdate>2016</risdate><volume>56</volume><issue>10</issue><spage>2438</spage><epage>2442</epage><pages>2438-2442</pages><issn>0041-1132</issn><eissn>1537-2995</eissn><coden>TRANAT</coden><abstract>BACKGROUND The treatment of patients with acute leukemia, who due to their religious beliefs refuse to accept blood transfusion, is a great challenge for hematologists. CASE REPORT We present a case of acute pre‐T‐lymphoblastic leukemia in a Jehovah's Witness who did not accept blood transfusion during chemotherapy. Standard induction and consolidation chemotherapy was used (according to the PALG ALL‐6 regiment). RESULTS During consolidation cycles, darbepoietin alfa, intravenous iron, and total parenteral nutrition was administered. Extreme (Hb &lt; 5 g/dL), long‐lasting (41 days) anemia was observed with the lowest Hb concentration amounting to 1.3 g/dL (lasting 7 days). CONCLUSION We believe this to be the lowest Hb value observed, particularly one that persisted for such a long period of time and resulted in the patient surviving without consequences. The patient remains in complete remission for more than 2 years after diagnosis.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27385671</pmid><doi>10.1111/trf.13703</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1132
ispartof Transfusion (Philadelphia, Pa.), 2016-10, Vol.56 (10), p.2438-2442
issn 0041-1132
1537-2995
language eng
recordid cdi_proquest_journals_1828424883
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Anemia - chemically induced
Anemia - therapy
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Blood Transfusion
Darbepoetin alfa - therapeutic use
Hematinics - therapeutic use
Hemoglobins - analysis
Humans
Iron - administration & dosage
Jehovah's Witnesses
Male
Parenteral Nutrition, Total
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Remission Induction
Treatment Refusal
Young Adult
title Long‐lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A13%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%E2%80%90lasting%20extreme%20anemia%20during%20the%20therapy%20of%20acute%20lymphoblastic%20leukemia%20in%20a%20Jehovah's%20Witness%20patient&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Chojnowski,%20Krzysztof&rft.date=2016-10&rft.volume=56&rft.issue=10&rft.spage=2438&rft.epage=2442&rft.pages=2438-2442&rft.issn=0041-1132&rft.eissn=1537-2995&rft.coden=TRANAT&rft_id=info:doi/10.1111/trf.13703&rft_dat=%3Cproquest_cross%3E4213980461%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1828424883&rft_id=info:pmid/27385671&rfr_iscdi=true